DE69927400D1 - Pge synthase und verfahren und mitteln zur modulation deren aktivität - Google Patents
Pge synthase und verfahren und mitteln zur modulation deren aktivitätInfo
- Publication number
- DE69927400D1 DE69927400D1 DE69927400T DE69927400T DE69927400D1 DE 69927400 D1 DE69927400 D1 DE 69927400D1 DE 69927400 T DE69927400 T DE 69927400T DE 69927400 T DE69927400 T DE 69927400T DE 69927400 D1 DE69927400 D1 DE 69927400D1
- Authority
- DE
- Germany
- Prior art keywords
- activity
- pge synthase
- modulating
- pge
- synthase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/553—Metal or metal coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10768798P | 1998-11-09 | 1998-11-09 | |
US107687P | 1998-11-09 | ||
PCT/EP1999/008363 WO2000028022A1 (en) | 1998-11-09 | 1999-11-02 | Pge synthase and methods and means for modulating its activity |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69927400D1 true DE69927400D1 (de) | 2006-02-02 |
DE69927400T2 DE69927400T2 (de) | 2006-06-29 |
Family
ID=22317930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69927400T Expired - Lifetime DE69927400T2 (de) | 1998-11-09 | 1999-11-02 | Pge synthase und verfahren und mitteln zur modulation deren aktivität |
Country Status (9)
Country | Link |
---|---|
US (4) | US6395502B1 (de) |
EP (1) | EP1129188B1 (de) |
JP (2) | JP4503849B2 (de) |
AT (1) | ATE305040T1 (de) |
AU (1) | AU770307B2 (de) |
CA (1) | CA2349529C (de) |
DE (1) | DE69927400T2 (de) |
ES (1) | ES2249042T3 (de) |
WO (1) | WO2000028022A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2249042T3 (es) * | 1998-11-09 | 2006-03-16 | Karolinska Innovations Ab | Pge sintasa y procedimientos y medios para la modulacion de su actividad. |
WO2001057225A1 (fr) * | 2000-02-03 | 2001-08-09 | Chugai Seiyaku Kabushiki Kaisha | Proteine regissant l'activite de la pge2 synthase et son utilisation |
EP1532242A4 (de) * | 2001-08-24 | 2005-12-07 | Pfizer Prod Inc | Verfahren zur herstellung gereinigter prostaglandin-e-synthase |
CA2468131A1 (en) * | 2001-11-30 | 2003-06-05 | Pfizer Products Inc. | Disruption of the prostaglandin e synthase 2 gene |
AU2003270900A1 (en) * | 2002-09-25 | 2004-04-19 | Pharmacia Corporation | Antisense modulation of microsomal prostaglandin e2 synthase expression |
WO2004067766A1 (en) * | 2003-01-27 | 2004-08-12 | Pfizer Products Inc. | Novel methods involving the determination of activity of enzymes that use or produce prostaglandin endoperoxide h2 |
WO2005024059A2 (en) * | 2003-09-09 | 2005-03-17 | Karolinska Innovations Ab | Methods for identifying compounds for inhibiting fever |
US7638331B2 (en) | 2004-01-02 | 2009-12-29 | The Administration of the Tulane Rducation Fund | Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery |
CA2639412A1 (en) * | 2007-09-11 | 2009-03-11 | Universite Laval | Prostaglandin e2 modulation and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US914356A (en) * | 1901-11-30 | 1909-03-02 | Harry Ward Leonard | Electric-circuit controller. |
EP1015624A2 (de) * | 1997-09-17 | 2000-07-05 | The Johns Hopkins University | P53 induzierte apoptosis |
ES2249042T3 (es) * | 1998-11-09 | 2006-03-16 | Karolinska Innovations Ab | Pge sintasa y procedimientos y medios para la modulacion de su actividad. |
-
1999
- 1999-11-02 ES ES99957275T patent/ES2249042T3/es not_active Expired - Lifetime
- 1999-11-02 CA CA002349529A patent/CA2349529C/en not_active Expired - Lifetime
- 1999-11-02 AU AU15041/00A patent/AU770307B2/en not_active Expired
- 1999-11-02 DE DE69927400T patent/DE69927400T2/de not_active Expired - Lifetime
- 1999-11-02 EP EP99957275A patent/EP1129188B1/de not_active Expired - Lifetime
- 1999-11-02 JP JP2000581189A patent/JP4503849B2/ja not_active Expired - Lifetime
- 1999-11-02 WO PCT/EP1999/008363 patent/WO2000028022A1/en active IP Right Grant
- 1999-11-02 AT AT99957275T patent/ATE305040T1/de not_active IP Right Cessation
- 1999-11-04 US US09/433,466 patent/US6395502B1/en not_active Expired - Lifetime
-
2002
- 2002-03-28 US US10/109,438 patent/US7067296B2/en not_active Expired - Lifetime
-
2004
- 2004-10-07 US US10/962,155 patent/US7192733B2/en not_active Expired - Lifetime
-
2007
- 2007-02-27 US US11/679,585 patent/US7645601B2/en not_active Expired - Lifetime
-
2010
- 2010-01-21 JP JP2010011053A patent/JP2010115205A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US20030064493A1 (en) | 2003-04-03 |
US7645601B2 (en) | 2010-01-12 |
US20080153107A1 (en) | 2008-06-26 |
CA2349529C (en) | 2009-10-27 |
JP4503849B2 (ja) | 2010-07-14 |
DE69927400T2 (de) | 2006-06-29 |
US6395502B1 (en) | 2002-05-28 |
WO2000028022A1 (en) | 2000-05-18 |
CA2349529A1 (en) | 2000-05-18 |
JP2002539762A (ja) | 2002-11-26 |
EP1129188B1 (de) | 2005-09-21 |
US20050118696A1 (en) | 2005-06-02 |
ATE305040T1 (de) | 2005-10-15 |
AU770307B2 (en) | 2004-02-19 |
EP1129188A1 (de) | 2001-09-05 |
ES2249042T3 (es) | 2006-03-16 |
US7192733B2 (en) | 2007-03-20 |
US7067296B2 (en) | 2006-06-27 |
JP2010115205A (ja) | 2010-05-27 |
AU1504100A (en) | 2000-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001038532A3 (en) | Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors | |
ATE520466T1 (de) | Apparat und verfahren zur modifizierung von magnetisch inmmobilizierte biomolekulen | |
ATE537264T1 (de) | Verfahren und zusammensetzungen für die gerichtete mikrowellenchemiie | |
AU7301898A (en) | Survivin, a protein that inhibits cellular apoptosis, and its modulation | |
DE69919151D1 (de) | Verfahren zur synthese von cox-2 inhibitoren | |
ATE536372T1 (de) | Verfahren zur hoher expression der aktiven form von lymphotoxin-beta-rezeptor-immunglobulin fusionsproteinen, und deren reinigung | |
DE60213803D1 (en) | Happier mapping | |
DE69927400D1 (de) | Pge synthase und verfahren und mitteln zur modulation deren aktivität | |
DE69823372T8 (de) | Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen | |
ATE344321T1 (de) | Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen | |
DE69431564D1 (de) | Reagenz zur behandlung von arthritischen zustaenden | |
WO2005060722A3 (en) | Modulation of immune system function by modulation of polypeptide arginine methyltransferases | |
DE50114193D1 (de) | Verfahren zur identifizierung von substanzen, die die aktivität von hyperpolarisations-aktivierten kationen-kanälen modulieren | |
ATE489478T1 (de) | Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation | |
ATE421090T1 (de) | Neues screening-verfahren von modulatoren der bakteriellen transkription | |
DE60227335D1 (de) | Kontinuierliches Verfahren zur Modifizierung von Stärke und Stärkederivate mittels Verzweigungsenzyme | |
AU2001275688A1 (en) | Multiplex sequencing method | |
AU2002361162A1 (en) | Evanescence-based multiplex sequencing method | |
DE59814359D1 (de) | Mikrostrukturierter biosensor, verwendung des biosensors und verfahren zur immobilisierung von biokatalysatoren | |
DE59608651D1 (de) | Verfahren zur sequenzierung durch oligomerhybridisierung | |
ATE363658T1 (de) | Molekülmodell für vla-4-inhibitoren | |
DE60129547D1 (de) | Verfahren zur kultivierung von mikroorganismen | |
BRPI0515397B8 (pt) | métodos para detecção e identificação específicas de streptococcus agalactiae usando atividade de esterase, e meio de reação | |
ATE412062T1 (de) | Verfahren und mittel zur detektion enzymatischer spalt- und verknüpfungsreaktionen | |
ATE264831T1 (de) | Verfahren zur cis-selektiven katalytischen hydrierung von cyclohexylidenaminen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |